Gabriel Lopez
Principal investigator, leads SYNVIVIA, INC..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$512KFederal grants as PI2 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $512K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Dec 1, 2021 | NSF | SBIR Phase I SBIR Phase I:Development of a Novel Biocontainment/Biosafety Platform Using Synthetic Auxotrophs | $256K | SYNVIVIA, INC. |
| Nov 26, 2021 | NSF | SBIR Phase I SBIR Phase I: Development of a Novel Biocontainment/Biosafety Platform Using Synthetic Auxotrophs | $256K | SYNVIVIA, INC. |
1 patents as inventor
- US SYNVIVIA, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#2,386
Awards as PI#1,252
Patents#273
Companies
- SYNVIVIA, INC.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.